Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
MediWound Ltd has a consensus price target of $21 based on the ratings of 6 analysts. The high is $36 issued by Oppenheimer on August 17, 2023. The low is $7 issued by Aegis Capital on March 21, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on November 27, 2024, October 11, 2024, and August 15, 2024, respectively. With an average price target of $27 between HC Wainwright & Co., there's an implied 63.74% upside for MediWound Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for MediWound (NASDAQ:MDWD) was reported by HC Wainwright & Co. on November 27, 2024. The analyst firm set a price target for $25.00 expecting MDWD to rise to within 12 months (a possible 51.61% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for MediWound (NASDAQ:MDWD) was provided by HC Wainwright & Co., and MediWound maintained their buy rating.
There is no last upgrade for MediWound
There is no last downgrade for MediWound.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MediWound, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MediWound was filed on November 27, 2024 so you should expect the next rating to be made available sometime around November 27, 2025.
While ratings are subjective and will change, the latest MediWound (MDWD) rating was a maintained with a price target of $28.00 to $25.00. The current price MediWound (MDWD) is trading at is $16.49, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.